Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending December 3, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending December 3, 2023

by Jonathan Hodson-Walker | Dec 6, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Nuvaira: The company raised $15.1 million of venture funding from undisclosed investors on November 30, 2023. The company is a developer of a medical device designed to improve outcomes for...
Healthcare Private Placement and M&A Transactions Review Week Ending November 26, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending November 26, 2023

by Jonathan Hodson-Walker | Nov 29, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions MBrace Therapeutics: The company raised $85 million of Series B venture funding in a deal led by TPG on November 21, 2023, putting the company’s pre-money valuation at $65 million....
Healthcare Private Placement and M&A Transactions Review Week Ending November 19, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending November 19, 2023

by Jonathan Hodson-Walker | Nov 22, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions VectorY Therapeutics: The company raised EUR 129 million of Series A venture funding in a deal led by Forbion and EQT Life Sciences on November 13, 2023. MRL Ventures Fund, Insight Partners,...
Healthcare Private Placement and M&A Transactions Review Week Ending November 12, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending November 12, 2023

by Jonathan Hodson-Walker | Nov 15, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Kyverna: The company raised $152 million of Series B venture funding in a deal led by Bain Capital Life Sciences, GordonMD Global Investments and Northpond Ventures on November 6, 2023. Gilead...
Healthcare Private Placement and M&A Transactions Review Week Ending November 5, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending November 5, 2023

by Jonathan Hodson-Walker | Nov 9, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions MapLight: The company raised $225 million of Series C venture funding in a deal led by Novo Holdings on October 30, 2023, putting the company’s pre-money valuation at $240 million. Cowen...
Healthcare Private Placement and M&A Transactions Review Week Ending October 29, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending October 29, 2023

by Jonathan Hodson-Walker | Nov 1, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Aiolos Bio: The company raised $245 million of Series A venture funding in a deal led by Atlas Venture, Bain Capital Life Sciences, Forbion and Sofinnova Investments on October 24, 2023. RA...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives